Joint Research and Development with SRL for Applications in Clinical Testing
First written in FY2017. 1 of 2 entries say "Dropped", first in FY2018. Latest entry: FY2018.
No other company in this theme has enough history to compare yet.
- FY2018DroppedAnnual report
「当社グループが中長期的に新たな事業領域として検討している分野は以下のとおりであります。」
エスアールエルとの臨床検査領域向け共同研究開発について、本 filing の事業状況・契約等では明示的な記載を確認できない。 - FY2017First statedAnnual report
「To apply deep-learning-based image-processing technology to specimen testing and create new technologies, including their protection through patents, we began an exclusive business alliance for joint development in this field with SRL, a subsidiary of Miraca Holdings, in April 2017 and are currently carrying out a joint research and development project. Total planned expenditures over five years are ¥410,000,000, comprising ¥303,000,000 in personnel expenses for additional researchers, ¥25,000,000 for development equipment and related procurement associated with the increase in researchers, and ¥82,000,000 for expansion of business facilities, including ¥62,000,000 in additional rent and ¥20,000,000 in initial costs for construction and equipment.」
Describes the exclusive joint development with SRL launched in April 2017, including progress in the initial development phase and planned five-year investment of ¥410,000,000 from January 2018 through December 2022.